{"disease":{"id":"chronic-hepatitis-c-chc","name":"chronic hepatitis c chc"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03868163","title":"Real World Evidence of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C in the Russian Federation","phase":"","overall_status":"COMPLETED","enrollment_count":161,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT01710501","title":"A Study of Different Doses of Grazoprevir (MK-5172) Given With Pegylated Interferon Alfa-2b and Ribavirin to Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-038)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":87,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}